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Abstract: Lyme disease is an emerging problem in Poland. Analysis has been undertaken of the medical 
documentation of 86 patients hospitalized in the Infectious Diseases Department, University Hospital in 
Cracow in 2013–2016, suspected of Lyme arthritis. It has especially considered medical history including 
potential exposure to the infection, detailed characteristics of the symptoms, diagnostic challenges and 
results of the treatment. Only some patients had a history of erythema migrans and not all of them recalled 
tick-bite. Th e majority of the patients had aff ected large joints, especially knee joints, and polyarthritis 
was rarely observed. Symptoms were resolved completely or partially aft er antibiotic treatment in most 
patients. Th e diagnosis of Lyme arthritis in areas endemic for Lyme disease is still a diagnostic challenge 
in patients with other rheumatic diseases, including osteoarthritis.
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Introduction
Th ere has been noticeable increase in the number of tick-borne diseases in Europe, 
Asia and North America in the past few years, with Lyme disease being of the highest 
incidence [1, 2]. Th is epidemiological data is similar in Poland. Due to the National 
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Institute of Hygiene, the number of reported cases of Lyme disease in Poland in 2017 
was 21,528, and the incidence rate was 56.02/100,000 population and was higher 
compared to 2016 [3, 4].
Lyme arthritis (LA) most commonly manifests itself in one ore few joints with 
non-characteristic, non-specifi c symptoms that can be commonly found in other 
diseases and usually requires diff erential diagnosis [5]. In patients not suff ering from 
LA antibodies, Borrelia burgdorferi sensu lato (B.  burgdorferi s.l.) can be present, 
which might lead to over-diagnosis of this disease and to introducing unnecessary, 
long-lasting antibiotic therapy.
Th e aim of this paper was the analysis of the data of patients treated for LA with 
consideration of diagnosis diffi  culties and results of the treatment.
Materials and Methods
We have analyzed the medical documentation of 86 patients, average age 55 years, 
hospitalized in the Infectious Disease Department, University Hospital in Cracow in 
2013–2016, suspected of LA. Th ere were 38 men and 48 women in this group. Patients 
were excluded if they had any of the following conditions: malignancies, autoimmune 
diseases, diseases that require immunosuppressive treatment, infl ammatory rheumatic 
diseases. Lyme disease was diagnosed and treated due to the recommendations 
of the Polish Society of Epidemiologists and Specialists of Infectious Diseases 
(PTEiLChZ) [6]. Antibodies were detected with enzyme-linked immunosorbent assay 
(test Elisa Biomedica, ELISA), positive or equivocal results were confi rmed with 
Western blotting (test Western blot Aescu, WB). Tick bites, presence of erythema 
migrans (EM), possible and correct antibiotic treatment due to EM, period of time 
between exposure and beginning of the symptoms were analyzed in patients’ medical 
history. Symptoms were analyzed considering pain and swelling of the joints, number 
of included joints, diagnosis of osteoarthritis. Patients were treated with ceft riaxone 
(2  g intravenously) or doxycycline (2 × 100 mg orally) for 28 days. Th e results of 
the treatment were analyzed in 2 groups of patients. Th e fi rst group (group I) were 
64  patients who were previously treated for LA with oral doxycycline 2 × 100 mg 
for 28 days with total or signifi cant improvement. We consider as a signifi cant 
improvement more than a  50% reduction in symptoms of pain/infl ammation of the 
joints (in the patient’s and physician’s opinions). Th e second group (group II) included 
22 patients who were not treated previously due to LA. Results for both groups were 
compared.
Th is paper is based on archival data from medical histories so the approval of 
Bioethical Commission is not required.
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Results
In 2013–2016, 86 patients suspected of LA were hospitalized in the Infectious Disease 
Department, University Hospital, Cracow. Patients were complaining of chronic, 
6 month-lasting joints pain. Positive IgG antibodies to B. burgdorferi s.l were detected 
in blood serum of this patients. In the analyzed group, 13 patients (15%) denied tick-
bite in the past, 53 patients (62%) reported multiple tick-bites, 20 patients (23%) 
reported single tick-bite.
In the analyzed group, 45 patients (52%) reported the presence of EM in the 
past, and in this group 17 were treated with antibiotics in the correct way, 10 patients 
received treatment with a delay of 1–2 months, 18 patients despite reporting EM 
were not treated with antibiotics at all. 9 patients who were correctly treated with 
antibiotics due to EM noticed other tick bites aft er this treatment, but without the 
symptoms of early Lyme disease.
Table 1. Presence of EM in analyzed group.
No EM in medical history 41 (48%)
Presence of EM in medical history, not treated 18 (21%)
Presence of EM in medical history, treated 27 (31%)
Th e period of time between a tick-bite and the beginning of the joints symptoms 
in the group of patients treated for EM most commonly was 2–12 months (6 patients) 
and over 2 years (6 patients) and 2–12 moths in the group of patients not treated for 
EM.
In the analyzed group, all patients complained of joints pain. Symptoms including 
1 joint were observed in 36 patients (42%); in 21 it was knee joint, symptoms 
including 2 joints were observed in 19 patients (22%), 3 joints in 13 patients (15%), 
4 in 6 patients (7%), 5 in 8 patients (9%), over 5 joints in 4 patients (5%). In physical 
examinations, swelling of the joints were seen in 32 patients (37%) at the admission 
to the hospital.
In the analyzed group, pain was most commonly present in the knee joint (81 
patients) and in the shoulder joint (51), least oft en in the hip joint (22 patients) and 
small joints of the hand (26 patients). Swelling most commonly was observed in the 
knee and foot joints. In the group of patients with aff ected knee joints, the highest 
incidence rate of osteoarthritis was observed.
8 Katarzyna Stażyk, Jacek Czepiel, et al.
Table 2. Localization and characteristic of the symptoms.
Localization Pain Swelling Osteoarthritis
knee 81 (94%) 11 30
hip 22 (25%) 0 7
foot 39 (45%) 11 16
elbow 33 (38%) 1 11
wrist 30 (35%) 4 10
hand 26 (30%) 5 8
shoulder 51 (59%) 0 15
In all 86 patients qualified for the treatment presence of IgG antibodies to 
B.  burgdorferi s.l. (ELISA and WB) was confi rmed, the presence of IgM antibodies 
ELISA was seen in 39 (45%) patients with positive WB in 10 amongst them (12%).
A CRP level within the norms was observed in 68 patients (79%), was moderately 
increased in 8 patients (9%), and in 10 (12%) patients CRP level was above 10 mg/l, 
reaching 51 mg/l in 1 patient.
In the group of 86 patients who were qualifi ed for the treatment, 81 were treated 
with ceft riaxone intravenously, the rest of them were treated with oral doxycycline. 
64 patients (group I) were previously treated with oral doxycycline for LA. 48 of them 
observed than complete relief of the symptoms, 16 observed signifi cant improvement. 
Recurrence of the symptoms occurred after 3–22 months. 22 patients were not 
treated previously with antibiotics (group II). All patients in group I were treated 
intravenously with 2 g ceft riaxone for 28 days, 17 patients in group II due to the 
contraindications for doxycycline received the same treatment, 5 patients in group II 
were treated with doxycycline.
Aft er the treatment in group I, a complete release of symptoms was observed in 
50 patients (78%), 14 patients (22%) reported signifi cant improvement. In group II in 
2 patients (9%) treated with ceft riaxone the symptoms remained the same, a complete 
improvement was observed in 13 patients (59%) and partial in 7 patients (32%).
In group I amongst those patients with a complete improvement aft er the fi rst 
treatment, recurrence of the symptoms was observed aft er 3–6 months in 29 patients, 
in 14 aft er 6–12 months, in 4 aft er 1–2 years.
Out of 16 patients with significant improvement after the first treatment, 
recurrence of the symptoms was observed aft er 3–6 months in 12 patients, and in 
4 aft er 6–12 months.
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Discussion
An etiological factor of Lyme disease are spirochetes of the B. burgdorferi s.l. 
complex, transmitted by Ixodes species ticks. Until now, there has been recognised 
18  genospecies, B. burgdorferi sensu stricto, B. garinii, B. afzelii i B. bavariensis are 
human pathogens, B. bissettii, B. valaisiana, B. lusitaniae, B. spielmanii are being 
conidered as potential human pathogens [5]. Skin, nervous system, joints and heart 
might be aff ected in this disease. LA is most commonly caused by B. burgdorferi sensu 
stricto. In Europe most commonly B. garinii and B. afzelii are seen so LA is relatively 
rare, it occurs in 3–25% of patients [6]. Tick-bite is necessary for infection, some 
patients don’t notice that fact though. Lack of tick-bite or EM presence in medical 
history doesn’t rule out the possibility of Lyme disease [7, 8].
Enkelmann et al. stated that amongst patients who were diagnosed with Lyme 
disease 71% of patients reported tick-bite and most often these were patients 
diagnosed with early, localized stage of the infection. Th e second most popular group 
were patients with neuroborreliosis and the smallest group-patients with LA [9]. In 
the analyzed group, 15% didn’t notice tick-bite, 62% noticed multiple tick-bites and 
23% singular.
Considering the duration and character of the symptoms in Lyme disease, we can 
distinguish the early, localized stage — most commonly EM, early disseminated stage 
and the late, chronic stage [10, 11]. Th e fi rst cases of Lyme disease were described in 
the 1970s in the USA by Steere et al., and it was noticed that an increased number 
of cases of recurrent joint pain, most commonly knee joints, with joints swelling in 
the summer months [12]. Before that, similar cases were diagnosed as rheumatoid 
arthritis [13].
In research conducted by Huppertz et al. in the group of 62 children with LA, 
only one person reported previous EM [14].
Steer et al. in research about the early stage of Lyme disease didn’t observe EM in 
18% of patients despite the presence of other symptoms caused by Lyme disease [15].
In the analyzed group, 52% of patients reported EM in medical history. Due to 
the standards of PSEaDID, this symptom is present in about 80% of patients, so in the 
analyzed group it was observed less oft en [6].
In the research of natural course of the disease conducted by Steer et al. in USA 
amongst patients who were not treated for EM, LA was observed in about 60% of 
patients, symptoms occurred averagely aft er 6 months and were present in one or few 
large joints, most oft en in knee joints [7, 16].
In Nardelli et al. research it was stated that symptoms including joints appear 
most oft en aft er few weeks to few months aft er the infection [17].
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In the analyzed group, amongst patients who were not treated for EM, the average 
time from tick-bite to the beginning of the symptoms was 2–12 months, amongst 
treated patients 2–12 months and over 2 years. In both groups, this period most oft en 
was 2–12 months, which is partially similar to other mentioned research. Correct 
treatment of EM prevents dissemination of the spirochetes and disseminated stage of 
the disease. In the group of 17 patients who were treated for EM, 9 of them reported 
another tick-bite aft er the treatment and could possibly be reinfected, another 8 didn’t 
notice tick-bite but still they could possibly be bitten, especially by the nymph of the 
tick. In 10 patients treatment was delayed by 1–2 months, which had an important 
infl uence on the development of the disseminated stage of the infection.
Joints involvement in Lyme disease can be observed in both early and late stage 
of the disease [18]. Th e disease is diagnosed in patients with arthritis in one or few 
joints, most oft en in large joints [19, 20]. Knee joint is the most common location; 
rarely is it localized in the temporomandibular joint and joints of feet and hands. 
Symptoms are usually asymmetrical [14, 20–23]. In physical examination of patients 
with LA swelling of the aff ected joint, it can be seen that the skin over it is usually 
warmed up and typically it causes little or no pain with passive range of motion [7]. In 
some cases, migrating pain of joints, muscles, muscles attachments and enthesis can 
be observed. It correlates with the results of our analysis, most common localization 
of symptoms were large joints-knee joint (84%) and shoulder joint (59%). Presence 
of the symptoms including joints of palms (30%) and feet (45%) were observed in 
patients with symptoms including large joints at the same time.
In the course of Lyme disease, monoarthritis or oligoarthritis is most often 
observed [6, 7, 16, 20, 24, 25]. In cases where more than one joint is involved, the 
number of involved joints is usually 2–4 [6, 16, 20]. Polyarthritis is not characteristic 
for LA and requires diff erential diagnosis for possible rheumatological diseases [7].
In the analyzed group, joints pain was reported by all patients, swelling of joints 
in 37% of patients. We observed that the majority of patients reported symptoms 
including one joint only (42%), the smallest number of patients were those with 
symptoms in 5 or more joints (4.6%). Symptoms of arthritis might be constant or 
can exacerbate in time [26]. During the course of the disease episodes are becoming 
longer, especially over 2 years of infection duration [7].
Th e level of CRP in the course of the LA is within the norms or only slightly 
elevated [27]. In the analyzed group, this parameter was normal in 79% of patients, in 
21% it was moderately elevated.
LA is diagnosed based on the symptoms and the presence of antibodies to 
B. burgdorferi s.l. in blood serum. Presence of antibodies to B. burgdorferi s.l. in 
people with no symptoms of Lyme disease is not enough reason for diagnosing this 
disease. In early stages of LA, there is a presence of IgM anitibodies and the level 
of IgG antibodies is increasing. In late stages of LA, the presence of IgM antibodies 
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has no diagnostic value [28, 29]. Serological testing of the synovial fluid is not 
recommended [30].
In the analyzed group, qualifi cations for treatment with antibiotic was based on 
the presence of symptoms and IgG antibodies to B.burgdorferi s.l. in blood serum. 
Some patients also were positive for IgM, but because symptoms were of at least 
6 months duration it didn’t have any diagnostic value.
According to the recommendations of PSEaDID, medication of choice in LA is 
doxycyline or ceft riaxone [6]. In some countries also, amoxicillin can be considered 
in LA treatment [6, 31]. Th ere has been no accurate evaluation of using cefuroxim 
in this group of patients [8]. If the treatment is correct, it leads to the eradication of 
spirochetes and in most patients to resolution of arthritis [7]. In about 10% of patients, 
with HLA-DRB1 0401, HLA-DRB1 0404 and HLA DRB1 0101 immunophenotypes 
suff ering from LA, despite antibiotic treatment chronic synovitis can be observed [13]. 
If the symptoms of LA persist for more than 3 months despite treatment, to rule out 
antibiotic-refractory arthritis and to confi rm the necessity of continuing the treatment 
Synovial fl uid PCR testing for B. burgdorferi DNA can be helpful [32]. In Poland this 
test has not been standardized [7].
In research by Huppertzi et al. in group of 62 children with LA, in 77% of them 
symptoms were resolved aft er 1 or 2 courses of antibiotic therapy [14].
According to available data, symptoms in most patients treated for LA are resolved 
aft er antibiotic therapy [33–35].
In the analyzed group, 64 patients (group I) were previously treated with 
doxycycline for LA. 75% of them noticed a complete improvement, 25% reported 
a partial improvement. Symptoms recurred aft er 3–12 months. 25% of patients were 
not previously treated with antibiotics (group II). All patients from group I and 
17  patients from group II were treated with ceft riaxone, 5 patients from group II 
were treated with doxycycline. Aft er the treatment in group I, 78% of patients noticed 
a complete resolution of the symptoms, 22% a partial improvement. In group II, 9% 
of patients didn’t notice any improvement, complete relief of symptoms was reported 
by 59% and partial by 32%. In the group of patients with partial improvement aft er 
the treatment sometimes further relief might be observed in the next few months 
aft er the treatment [31].
Some of the patients in the analyzed group were also diagnosed with osteoarthritis, 
which was the reason of diagnosing diffi  culties. Th e incidence rate of osteoarthritis 
increases with age, in people over 55 years it is diagnosed in about 80%. Exacerbation 
of symptoms of osteoarthritis might lead to diffi  culties in estimation of the symptoms 
of LA [36, 37].
In the analyzed group, 32 patients were diagnosed with osteoarthritis, and in 30 of 
them the knee joint was involved. In these patients aft er the antibiotic treatment, relief 
of symptoms or partial improvement was observed, however in such cases condition 
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of the patient should be carefully evaluated before stating the diagnosis, especially due 
to the possible presence of antibodies against B.burgdorferi s.l.
The diagnosis of LA in endemic for Lyme disease areas is still a diagnostic 
challenge in patients with other infl ammatory arthritides.
Conclusions
1. Th e results of our analysis confi rm that some patients don’t notice tick-bite, EM is 
not present in all patients.
2. Delayed antibiotic treatment of EM might cause the dissemination of infection 
with B.burgdorferi s.l.
3. Symptoms of LA usually aff ect large joints, especially knee joints.
4. In LA symptoms most oft en aff ect one to four joints.
5. In LA recurrence of the symptoms is possible, it indicates the need for long lasting 
antibiotic therapy.
6. High incidence rate of osteoarthritis, especially in people over 55 years of age and 
possible presence of antibodies against B.burgdorferi s.l. in people not suff ering 
from LA is the reason of problems in diagnosing LA.
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